欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/1015/003
药品名称Progedex
活性成分
    • Progesterone 25.0 mg
剂型Solution for injection in pre-filled syringe
上市许可持有人IBSA Farmaceutici Italia S.r.l. Via Martiri Di Cefalonia 2 26900 Lodi Italy
参考成员国 - 产品名称Austria (AT)
Progedex 25 mg Injektionslösung in einer Fertigspritze
互认成员国 - 产品名称
    • Poland (PL)
    • Belgium (BE)
    • Latvia (LV)
    • Netherlands (NL)
    • Lithuania (LT)
      -
    • Luxembourg (LU)
    • Estonia (EE)
    • France (FR)
    • Hungary (HU)
      Prolutex 25 mg oldatos injekció előretöltött fecskendőben
    • Ireland (IE)
    • Spain (ES)
    • Bulgaria (BG)
      Prolutex Ready
    • Portugal (PT)
    • Cyprus (CY)
      Prolutex 25 mg, Ενέσιμο διάλυμα σε προγεμισμένη σύριγγα
    • Italy (IT)
    • Czechia (CZ)
      Prolutex Ready
    • Greece (GR)
    • Romania (RO)
    • Sweden (SE)
    • Slovakia (SK)
    • Norway (NO)
    • Germany (DE)
      Prolutex Ready 25 mg in einer Fertigspritze
    • Finland (FI)
    • Denmark (DK)
许可日期2023/07/20
最近更新日期2025/01/27
药物ATC编码
    • G03DA04 progesterone
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase